Line V. Hjelle

University Hospital of North Norway

Papers

1

Total Citations

3

H-Index

1

About

Line V. Hjelle is a dedicated clinical researcher whose work centers on patient-reported outcomes and quality of life following curative treatments for prostate cancer. Her major contributions lie in systematically evaluating the adverse health effects and toxicities associated with prostatectomy, primary radiotherapy, and salvage radiotherapy, using patient-reported outcome measures (PROMs) to capture real-world experiences often missed in clinical trials. Her 2023 study, which has garnered 3 citations, addresses critical gaps in understanding how modern treatment techniques impact patients’ long-term well-being, offering valuable insights for shared decision-making. Hjelle’s research is notable for its focus on the patient’s voice, bridging the gap between clinical efficacy and lived experience. By highlighting the trade-offs between treatment modalities, she empowers clinicians and patients to make more informed choices. Her work is a vital resource for oncologists, urologists, and researchers striving to improve survivorship care. For students and researchers, Hjelle exemplifies how rigorous PROMs research can transform cancer care from purely survival-focused to patient-centered.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Patient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapy
3 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: University Hospital of North Norway

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago